Evidence map›Paper›PMID 18325678›Full record

ArticlePsychoneuroendocrinology2008

Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys.

John E Pascoe, Keith L Williams, Partha Mukhopadhyay, Kenner C Rice, James H Woods, Mei-Chuan Ko

Open access · greenAbstract readComparative Study
In one paragraph

Article in Psychoneuroendocrinology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Kappa opioid receptor control of motivated behavior revisited.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  5. Review
  6. Article
  7. The influence of drug class on reward in substance use disorders.Pharmacology, biochemistry, and behavior · 2024
    Review
  8. Opioid Mechanisms and the Treatment of Depression.Current topics in behavioral neurosciences · 2024
    Review
  9. Review
  10. Review
  11. The opioid system in depression.Neuroscience and biobehavioral reviews · 2022
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

John E PascoeDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Keith L Williams
Partha Mukhopadhyay
Kenner C Rice
James H Woods
Mei-Chuan Ko
University of Michigan–Ann Arbor · USNational Institute on Drug Abuse · USOakland University · US

Funding

Selective radiolabeled agonists /antagonists for opiate receptor subtypesP50DA000254 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHANSON, CHRIS-ELLYN · 1985 to 2002
$5.0M
Narcotic Drug and Opioid Peptide Basic Research projectP01DA000254 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WOODS, JAMES H · 2003 to 2006
$5.0M
Design and synthesis of drugs acting on central and peripheral tissuesZ01DA000520 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER C · 2007 to 2007
$4.7M
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid ReceptorsZ01DA000527 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2008 to 2008
$2.1M
Intrathecal Opioid-Induced PruritusR01DA013685 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KO, MEI-CHUAN · 2001 to 2003
$735k
COGNITIVE INTERVENTION FOR DRUG ABUSING ADOLESCENTSK21DA000254 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LATIMER, WILLIAM W · 1995 to 1999
–
NIDA NIH HHS DA-013685NIDA NIH HHS K21 DA000254NIDA NIH HHS P01 DA000254NIDA NIH HHS P50 DA000254NIDA NIH HHS R01 DA013685
6 · The paper itself

Abstract

Opioids can modulate neuroendocrine function. Less is known about the involvement of opioid receptor subtypes in the stimulatory effects of opioids on the primate hypothalamic-pituitary-adrenal (HPA) axis. The aim of this study was to investigate the stimulatory effects of opioids selective for each receptor subtype on plasma adrenocorticotropic hormone (ACTH) and cortisol levels in both male and female monkeys. The blood collection procedure was conducted in home-caged and unanesthetized rhesus monkeys that showed low and stable basal ACTH and cortisol levels. Three opioid receptor agonists, fentanyl, U-50488H, and SNC80, were used in behaviorally active doses; they are highly selective for mu, kappa, and delta opioid receptors, respectively. Plasma samples were collected at multiple time points before and after IV administration of each compound and were quantified by radioimmunoassay. Neither fentanyl (0.0003-0.02mg/kg) nor SNC80 (0.03-0.3mg/kg) changed either ACTH or cortisol basal levels. In contrast, U-50488H (0.01-1mg/kg) dose-dependently stimulated ACTH and cortisol release in both male and female monkeys. Importantly, the stimulatory effects of U-50488H on the secretion of ACTH were blocked by a selective kappa opioid receptor antagonist, nor-Binaltorphimine. The antagonist effect of nor-binaltorphimine lasted up to 20 weeks. These results indicate that only synthetic kappa, but not mu or delta opioid receptor agonists stimulate HPA axis activity after acute administration in primates.

Indexed as

3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-IsomerAdrenocorticotropic HormoneAnalgesics, OpioidAnimalsArea Under CurveBenzamidesDose-Response Relationship, DrugFemaleFentanylHydrocortisoneHypothalamo-Hypophyseal SystemMacaca mulattaMalePiperazinesPituitary-Adrenal SystemReceptors, Opioid3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamideAdrenocorticotropic HormoneAnalgesics, OpioidBenzamidesFentanylHydrocortisonePiperazinesReceptors, OpioidReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, mu

Identifiers

PMID18325678
PMCPMC2443864
OpenAlexW2104650852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.